Safety of long-acting beta2-agonists in the management of asthma: a Primary Care Respiratory Alliance of Canada perspective.
Department of Family and Community Medicine, University of Toronto, Ontario, Canada. tonydurzo@sympatico.ca
Anthony D
AD
D'Urzo
Pieter
P
Jugovic
Jacques
J
Bouchard
Reuven
R
Jhirad
Itamar
I
Tamari
D058666:Adrenergic beta-2 Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000517:prevention & control; D003692:Delayed-Action Preparations; D004359:Drug Therapy, Combination; D006801:Humans
D058666:Adrenergic beta-2 Receptor Agonists; D003692:Delayed-Action Preparations